EcoDrugPlus

Solute Carrier Family 5 Member 1

Ensembl ID : ENSLOCG00000001416
Gene Symbol: SLC5A1
1 Cross references
250 Possible Orthologues:

Solute Carrier Family 6 Member 1

Ensembl ID : ENSLOCG00000013915
Gene Symbol: SLC6A1
3 Cross references
278 Possible Orthologues:

Solute Carrier Family 6 Member 2

Ensembl ID : ENSLOCG00000007036
Gene Symbol: SLC6A2
3 Cross references
203 Possible Orthologues:

Solute Carrier Family 6 Member 3

Ensembl ID : ENSLOCG00000008899
Gene Symbol: SLC6A3
3 Cross references
166 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSLOCG00000002674
Gene Symbol: SLC6A9
3 Cross references
208 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSLOCG00000008029
Gene Symbol: SLC9A3
2 Cross references
233 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSLOCG00000017701
Gene Symbol: SSTR1
3 Cross references
158 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSLOCG00000017755
Gene Symbol: SSTR2
3 Cross references
263 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSLOCG00000017606
Gene Symbol: SSTR4
3 Cross references
206 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSLOCG00000011379
Gene Symbol: SSTR5
1 Cross references
189 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSLOCG00000017643
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSLOCG00000008182
Gene Symbol: SYK
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).